Efficacy and safety of ultra-rapid lispro insulin in managing type-1 and type-2 diabetes: A systematic review and meta-analysis
Background: Mechanistically, subcutaneous ultra-rapid lispro (URLi) is faster than lispro. Whether this translates into a better post-prandial glucose (PPG) and glycemic control in type-1 diabetes (T1DM) and type-2 diabetes (T2DM) is unclear. Hence, we undertook this meta-analysis. Methods: Database...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Edice: | Indian Journal of Endocrinology and Metabolism |
| Témata: | |
| On-line přístup: | http://www.ijem.in/article.asp?issn=2230-8210;year=2023;volume=27;issue=6;spage=467;epage=475;aulast=Dutta |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|